CombiMatrix and Furuno Launch DNA Microarray Synthesizer; New CE Marked Instrument Incorporates Reagents and Arrays in a Single Stand-Alone Unit.NEWPORT BEACH Newport Beach, residential and resort city (1990 pop. 66,643), Orange co., S Calif., on Newport Bay and the Pacific Ocean; inc. 1906. It is a popular seaside resort and yachting center. Manufactures include electrical and medical equipment, computers, boats, and adhesives. , Calif. -- Acacia Research Corporation (Nasdaq:ACTG ACTG Acting ACTG AIDS Clinical Trial Group ACTG Actuating/Actuator ) (Nasdaq:CBMX) announced today that its CombiMatrix group, working in partnership with Furuno Electric Co., Ltd. of Japan, has launched its new QuadroCAS(TM) CustomArray(TM) Synthesizer synthesizer Machine that electronically generates and modifies sounds, frequently with the use of a digital computer, for use in the composition of electronic music and in live performance. . Jointly designed and developed by the two companies, this new instrument integrates CombiMatrix's proprietary electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies. e·lec·tro·chem·i·cal adj. in situ In place. When something is "in situ," it is in its original location. oligonucleotide synthesis technology into a compact, stand-alone design. Manufactured by Furuno at their instrument production facility in Japan, the QuadroCAS Synthesizer combines convenient and reliable reagent handling hardware with state of the art Furuno instrument control and signal processing electronics to deliver a full-featured, small footprint instrument for CustomArray production applications. Designed and tested to meet appropriate safety certification standards, the QuadroCAS Synthesizer will bear the CE ("European Conformity") and TUV (Technischer Überwachungs-Verein) Literally "Technical Watch-Over Association." A German certifying body involved with product safety for the European community. markings (i.e., tested by TUV to meet the minimum requirements of prescribed product safety standards) and is suitable for worldwide distribution. Using this instrument, researchers around the world will be able to rapidly produce custom DNA microarrays to their exact specifications with complete control over the content. Hidetoshi Tanigaki, Managing Director and General Manager of Furuno, said, "We are excited about the launch of the new QuadroCAS DNA Microarray Synthesizer. This instrument represents an important new product line for the life-science business group at Furuno." "The QuadroCAS Synthesizer expands our synthesis product line," said Michael Tognotti, Vice President of Sales and Marketing of CombiMatrix. "We look forward to offering our customers this dynamic enabling instrument." The QuadroCAS Synthesizer fabricates CombiMatrix CustomArray microarrays that contain thousands of microelectrodes that are individually addressable Reachable. When something is addressable, it can be identified and manipulated independently of its surroundings. For example, screen pixels and RAM memory are addressable. Each of the screen's picture elements can be individually turned on and off, and each of the memory's bytes can be using embedded logic circuitry on the microarray. Placed in one of four specially designed fluidic flu·id·ic adj. 1. Of, relating to, or characteristic of a fluid. 2. Relating to or controlled by fluidics. chambers, the system software digitally directs the molecular assembly of oligonucleotides for each separate array. During this process thousands of different oligonucleotide probes can be synthesized simultaneously on four different individual arrays. Features on the new QuadroCAS Synthesizer include: --The QuadroCAS Synthesizer, along with the CombiMatrix CustomArray Synthesizer(TM), are the only commercially available DNA microarray synthesizer instruments in the marketplace, providing high quality in situ fabricated arrays on demand. --The QuadroCAS Synthesizer fabricates up to 4 high quality in situ arrays simultaneously with the same or unique probe designs in 24 hours or less, depending on the array format of the experiments run. --The QuadroCAS Synthesizer allows the flexibility to design each probe sequence to the exact specification of the user for any organism and allows customers complete control over inventory for on-demand in situ microarrays. -- The QuadroCAS Synthesizer has a compact footprint and incorporates all reagents and hardware into a stand-alone instrument. -- The QuadroCAS Synthesizer will be certified by TUV to be compliant to EU directive IEC (International Electrotechnical Commission, Geneva, Switzerland, www.iec.ch) An organization that sets international electrical and electronics standards founded in 1906. It is made up of national committees from over 60 countries. IEC - International Electrotechnical Commission 61010-1 73/23/EEC and 89/336/EEC with the latest amendments 92/31/EEC and 93/68/EEC. More information on the CombiMatrix QuadroCAS Synthesizer and other CombiMatrix instruments may be found on the CombiMatrix website -- www.combimatrix.com. ABOUT FURUNO Furuno Electric Co. Ltd. (Hyogo, Japan) has built a firm position as the world's leading manufacturer of innovative marine electronic equipment. Since Furuno put the world's first fish finder into practical use in 1948, Furuno has been steadily expanding its activities to cover a wider range of market sectors. Now, Furuno applies its sophisticated electric, ultrasonic and computer technologies to avionic equipment, marine radar, sonar, and navigation systems, GPS survey systems, data management devices for office and store automation and medical electronic equipment. ABOUT ACACIA RESEARCH CORPORATION Acacia Research Corporation comprises two operating groups, Acacia Technologies group and CombiMatrix group. The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology. The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 47 patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency co·her·en·cy n. pl. co·her·en·cies Coherence. Noun 1. coherency - the state of cohering or sticking together coherence, cohesion, cohesiveness , credit card fraud Credit card fraud is a wide-ranging term for theft and fraud committed using a credit card or any similar payment mechanism as a fraudulent source of funds in a transaction. The purpose may be to obtain goods without paying, or to obtain unauthorized funds from an account. protection, database management, data encryption & product activation, digital media transmission (DMT See DSL. (R)), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, hearing aid ECS See eComStation. , image resolution enhancement, interactive data sharing, interactive television, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging, spreadsheet automation, user activated Internet advertising and web conferencing & collaboration software. Acacia Research-Acacia Technologies (Nasdaq:ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups. Information about the Acacia Technologies group and the CombiMatrix group is available at www.acaciaresearch.com. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. , recent and forthcoming Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. , recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion